Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of High Dose vs. Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3, High Viral Load Without Rapid Virological Response

NCT00830609 is registered in ClinicalTrials.gov with Dr. Conrado Fernandez as lead sponsor.

NCT NCT00830609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00830609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of High Dose vs. Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3, High Viral Load Without Rapid Virological Response
Lead sponsor
Dr. Conrado Fernandez
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2008
Completion date
December 31, 2011
Enrollment
101 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c